Conversion to sirolimus after kidney and liver transplantation: indications and outcomes.
Wramner
L
L
Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden. lars.wramner@spray.se
Norden
G
G
Herlenius
G
G
Friman
S
S
Olausson
M
M
Bäckman
L
L
D000328:Adult; D000368:Aged; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology; D008875:Middle Aged; D020123:Sirolimus / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D020123:Sirolimus